Estimated Preliminary Control Closed Transaction verified Consumer Health

Cooper Consumer Health acquired by CVC Capital Partners and Avista

CVC Capital Partners and Avista acquired Cooper Consumer Health, a France & Europe consumer health brand, on Oct 15, 2021.

Preliminary: The transaction value, EV/revenue and EV/EBITDA are not yet independently verified.

Transaction summary

Target
Cooper Consumer Health
Announced
2021-03-12
Completed
2021-10-15
Geography
France & Europe
Tags
Consumer Health
1 more tag
Type
Acquisition
Deal type
Control
Stake acquired
-
First added
2026-10-31
Latest update
2026-10-31

Value and multiples

100% enterprise value

EUR 2.2B

Unverified

100% enterprise value | EUR

Basis: Reported / rumored

Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.

Approx. $2.6B USD using FX date 2021-03-08 at 1.1866 EUR/USD.

EV / revenue

4.44x

Unverified

Period: FY2020

Basis: Estimated

EV / EBITDA

14.2x

Unverified

EBITDA basis not stated

Basis: Estimated

Amounts paid and other reported values

Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.

Consideration: EUR 2.2B

Basis

  • Press-reported value: €2.2bn. Multiples use revenue of €496m (FY2020) and EBITDA of €155m (FY2020).

Source summary

CVC buys Cooper from Charterhouse for EUR2.2bn (Unquote)

Estimated

The deal values the business at €2.2bn, according to a source familiar with the situation

Open source

Continue your research

Explore more comps →